IQVIA Holdings, Inc. (IQV)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about IQVIA Holdings, Inc. (IQV)
Company Performance

Current Price

as of Nov 25, 2024

$204.02

P/E Ratio

26.76

Market Cap

$37.03B

Description

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Metrics

Overview

  • HQDurham, NC
  • SectorHealth Services
  • IndustryServices to the Health Industry
  • TickerIQV
  • Price$204.02+1.09%

Trading Information

  • Market cap$37.03B
  • Float99.18%
  • Average Daily Volume (1m)2,249,036
  • Average Daily Volume (3m)1,476,271
  • EPS$7.72

Company

  • Revenue$15.31B
  • Rev growth (1yr)4.06%
  • Net income$285.00M
  • Gross margin28.18%
  • EBITDA margin21.91%
  • EBITDA$853.00M
  • EV$55.64B
  • EV/Revenue3.63
  • P/E26.76
  • P/S2.45
  • P/B5.32